United States v. Bruner

657 F.2d 1278, 212 U.S. App. D.C. 36
CourtCourt of Appeals for the D.C. Circuit
DecidedJune 23, 1981
DocketNos. 79-1769 to 79-1772, 79-1774, 79-1784, 79-1785 and 80-1773
StatusPublished
Cited by69 cases

This text of 657 F.2d 1278 (United States v. Bruner) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Bruner, 657 F.2d 1278, 212 U.S. App. D.C. 36 (D.C. Cir. 1981).

Opinion

Opinion for the Court filed by Circuit Judge MacKINNON.

MacKINNON, Circuit Judge:

Following a four-month jury trial1 on an indictment2 charging unlawful distribution of a controlled substance, interstate travel in aid of a racketeering enterprise, and conspiracy to distribute narcotic drugs, the seven appellants were convicted.3 Central [41]*41to the charges was a six-year multi-state drug conspiracy centered in Washington, D. C.

I. THE CONSPIRACY

This case involves the so-called “Fat Lady Conspiracy” which operated under the direction and control of Carl Lynch and a few trusted confederates. They sent groups of overweight women on a regular basis to Philadelphia and New York, and sporadically to Pittsburgh, Atlanta, Miami, and Birmingham. The object of the conspiracy was the acquisition and distribution of Preludin and Dilaudid. Escorted by “team leaders,” these groups of women visited doctors in an endeavor to obtain prescriptions for Preludin, a drug prescribed to induce weight loss, and, by complaining of pain, to obtain prescriptions for the pain-reliever Dilaudid. Lynch and his team leaders provided housing for the women and maintained a fleet of automobiles to transport them to the doctors’ offices. The team leaders paid for the visits to doctors and, after the women obtained prescriptions for the drugs, transported the women to pharmacies and paid to have the prescriptions filled. Each of the women was paid an amount for each prescription, usually twenty-five dollars. Once the prescriptions were filled, couriers would bring the drugs to Washington, where they were sold from various locations in the Washington metropolitan area by members of the conspiracy.

The conspiracy apparently began in Washington, D. C. in 1972. When Preludin became difficult to acquire in Washington, the conspirators began to look to other cities. In both Philadelphia and New York they discovered doctors who were willing to regularly prescribe large quantities of Preludin. In Philadelphia one doctor prescribed significant quantities to the same women several times a day. Another doctor there put one of the members of the conspiracy on his payroll. That doctor prescribed Preludin on the basis of cards on file in his office, without requiring a visit by the “patient.” He was paid ten dollars per prescription. One witness testified that she delivered a single payment of $10,000 to this doctor from Carl Lynch. Both of these ■doctors died during the course of the conspiracy, but others took their places, operating in a similar fashion. One, Dr. Lee Hedson, was ultimately indicted. The Philadelphia network was active up to the time the grand jury returned the indictment. The operation of the conspiracy in New York City followed a similar pattern. Two doctors who participated actively in the conspiracy, Dr. Gus Bashien and Dr. Alfred Calfon, were indicted.

II. APPELLANTS’ ARGUMENTS

A. The Bashien- Prescriptions

John Bruner and Carl Lynch make three assertions of error based on the admission into evidence of approximately 5,000 prescriptions and other documents obtained from the offices of Dr. Gus Bashien. First, they argue that the prescriptions were improperly authenticated. Second, they argue that they were denied their Sixth Amendment rights to confront a witness against them. Third, Lynch contends that the prescriptions were inadmissible hearsay.

It is the Government’s position that the prescriptions were properly admitted. It argues first that the prescriptions were not hearsay and, that even if they were, they were properly admitted under the business records exception. The Government points to the testimony of George Ginsberg, a pharmacist for the State of New York, and Margaret Brophy, a Drug Enforcement Administration investigator, as sufficiently authenticating the documents and as providing the necessary information to support the business records exception. Finally, the [42]*42Government argues that the documents were properly admitted, although the preparer of documents did not testify, because the reliability and trustworthiness of the documents were otherwise established.

1. Authentication

Testimony of the author is but one way to authenticate documents; circumstantial evidence of authenticity can be sufficient. McCormick on Evidence § 222 (2d ed. 1972). Here, the testimony given by Ginsberg and Brophy adequately authenticated the prescriptions. Ginsberg testified that under New York law, N.Y.Pub. Health Law § 3338 (McKinney), physicians must write prescriptions on state-issued triplicate forms, one copy of which is retained by the doctor on all prescriptions for Schedule II drugs.4 Transcript (Tr.) at 346-64. He testified that he was responsible for maintaining the state’s stock of blank prescription pads and the copies of filled prescriptions sent to the state by pharmacists.5 Brophy identified the prescriptions offered in evidence as those obtained by her from Dr. Bashien pursuant to subpoena. Finally, Ginsberg testified that the seized prescriptions matched the numbers of the prescriptions which had been issued to Dr. Bashien, with but two exceptions.6

“[Pjroof of private custody, together with other circumstances, is frequently strong circumstantial evidence of authenticity.” McCormick on Evidence § 224 (2d ed. 1972). Accord, United States v. King, 472 F.2d 1, 7-8 (9th Cir. 1972), cert. denied, 414 U.S. 1033, 94 S.Ct. 463, 38 L.Ed.2d 325 (1973). The “other circumstances” here include the method by which the State of New York issues and accounts for prescription blanks, as described by Ginsberg. This, when added to Brophy’s testimony that the prescriptions were obtained from Dr. Bashien by subpoena, is substantial proof of authenticity, and is “evidence sufficient to support a finding that the matter in question is what its proponent claims.” Fed.R.Evid. 901(a).

2. Hearsay

These documents are hearsay only if they contain “statements . . . offered in evidence to prove the truth of the matter asserted” and they are not “statement[s] by a coconspirator of a party during the course and in furtherance of the conspiracy.” Fed.R. Evid. 801(c), (d)(2)(E).

The prescriptions are divided into three sections. One section contains the name and address of the physician and the patient and the date the prescription is written. The second section is comprised of the name of the drug prescribed, the directions for its use, and the maximum daily dose. The third section is reserved for use by the pharmacist to enter information such as his and the drug’s identification numbers and the date the drug is dispensed. Tr. at 350-51.

In our view, the prescriptions were not admitted to prove the truth of the assertions they contained, and are, therefore, not hearsay. They were not offered to prove Dr. Bashien’s or any of his patients’ addresses.7

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pietrangelo v. Refresh Club, Inc
District of Columbia, 2023
United States v. Deangelo Jenkins
984 F.3d 1038 (D.C. Circuit, 2021)
United States v. McCormick
District of Columbia, 2019
State v. Young
198 A.3d 806 (Court of Appeals of Maryland, 2018)
United States v. Simmons
155 F. Supp. 3d 60 (District of Columbia, 2016)
United States v. Ford
155 F. Supp. 3d 60 (District of Columbia, 2016)
United States v. Lenny Cain
586 F. App'x 104 (Fourth Circuit, 2014)
United States v. Michael Matthews
753 F.3d 1321 (D.C. Circuit, 2014)
United States v. Burroughs
905 F. Supp. 2d 297 (District of Columbia, 2012)
United States v. Scurry
District of Columbia, 2012
United States v. Savoy
889 F. Supp. 2d 78 (District of Columbia, 2012)
United States v. Moore
651 F.3d 30 (D.C. Circuit, 2011)
United States v. Jones
451 F. Supp. 2d 71 (District of Columbia, 2006)
United States v. Tann
425 F. Supp. 2d 26 (District of Columbia, 2006)
United States v. Brodie
326 F. Supp. 2d 83 (District of Columbia, 2004)
Holy Land Foundation for Relief & Development v. Ashcroft
219 F. Supp. 2d 57 (District of Columbia, 2002)
Weaver v. State
678 So. 2d 260 (Court of Criminal Appeals of Alabama, 1995)
United States v. James Brown, A/K/A Steven Brown
16 F.3d 423 (D.C. Circuit, 1994)
United States v. Jones
First Circuit, 1993

Cite This Page — Counsel Stack

Bluebook (online)
657 F.2d 1278, 212 U.S. App. D.C. 36, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-bruner-cadc-1981.